ADC Therapeutics SA
ADCT
$1.33
-$0.02-1.48%
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
--
Headlines
4/1/2025
-
GuruFocus
4/1/2025
-
PR Newswire
4/1/2025
-
MarketBeat
4/1/2025
-
MarketBeat
4/1/2025
-
GuruFocus
4/1/2025
-
PR Newswire
4/1/2025
-
GuruFocus
3/31/2025
-
GuruFocus
3/31/2025
-
The Fly
3/29/2025
-
MarketBeat
3/28/2025
-
Simply Wall St
3/27/2025
-
GuruFocus
3/27/2025
-
SeekingAlpha.com: All News
3/27/2025
-
Seeking Alpha: Transcripts
3/27/2025
-
SeekingAlpha
3/27/2025
-
GuruFocus
3/27/2025
-
GuruFocus
3/27/2025
-
Zacks Investment Research
3/27/2025
-
SeekingAlpha
3/27/2025
-
The Fly
3/27/2025
-
SeekingAlpha.com: All News
3/27/2025
-
PR Newswire
3/25/2025
-
GuruFocus
3/25/2025
-
PR Newswire
3/25/2025
-
SeekingAlpha
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Thursday, March 27, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of May 5 and 9 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
41 21 653 02 00
Address
BiopOle
Epalinges, 1066
Epalinges, 1066
Country
Year Founded
Business Description
Sector
ADC Therapeutics SA focuses on advancing its proprietary antibody drug conjugate (ADC) technology platform to transform the treatment paradigm for patients with hematologic malignancies and solid...
more
